Antagomir-350-3p
Antagomir-350-3p has been studied in 1 paper since 2024: none in people yet, 1 in animals. The research so far is in animals. The newest paper, May 8, 2024: “Macrophage-derived ectosomal miR-350-3p promotes osteoarthritis progression through downregulating chondrocyte H3K36 methyltransferase NSD1”.
1 paper studies it2 findingsUpdated
- 1 lab in 1 country
- Funders: Guangzhou Medical University and 1 more
- Animals1
What did studies of Antagomir-350-3p find?
2Studies of Antagomir-350-3p measured 2 outcomes; the most studied are cellular senescence (1 study) and osteoarthritis (1).
Cellular senescence
downin mice1
1 study
Cellular senescence
downin mice1
Antagomir-350-3p decreases cellular senescence in mice.
“intra-articular injection of antagomir-350-3p inhibited the increase of miR-350-3p and alleviated cartilage degeneration and senescence”
Animalsexperimental OAintra-articular injectioncartilage
Cell death discovery
Osteoarthritis
downin mice1
1 study
Osteoarthritis
downin mice1
Antagomir-350-3p decreases osteoarthritis in mice.
“intra-articular injection of antagomir-350-3p inhibited the increase of miR-350-3p and alleviated cartilage degeneration and senescence”
Animalsexperimental OAintra-articular injectioncartilage
Cell death discovery